Roche Chairman Franz B. Humer announces that he will not stand for re-election in 2014
Posted: 5 March 2013 | | No comments yet
Roche to inform about plans for succession in autumn 2013…
![Roche logo](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Roche-Logo.gif)
![Roche logo](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Roche-Logo.gif)
Franz B. Humer, Chairman of the Board of Directors of the Roche Group, announced at today’s Annual General Meeting that he will not stand for re-election to the Board in 2014. Roche will nominate a successor for the chairmanship in autumn 2013. The Roche Board has decided that Franz Humer’s successor will also serve as non-executive Chairman, thus maintaining the established separation of the offices of Chairman and Chief Executive Officer.
Roche Chairman Franz B. Humer: “Roche is in excellent shape and well positioned to meet future challenges. This is a good time to hand over to a successor. I am looking forward to the next 12 months, and I intend to perform my duties as Chairman with enthusiasm and drive.”